Study Finds KRAS Testing in Metastatic CRC Saves Money, but Questions Value

Study Finds KRAS Testing in Metastatic CRC Saves Money, but Questions Value

Filed under: drug treatment news 2011

Although implementing genetic testing for KRAS and BRAF to guide anti-EGFR treatment can save payors around $ 8,000 per patient compared to administering these drugs without PGx testing, the study results indicate that the cheapest strategy would be to …
Read more on GenomeWeb

 

Statins and Exercise, Independently Beneficial, Even Better In Combination

Filed under: drug treatment news 2011

“The fitness necessary to attain protection that is much the same or greater than that achieved by statin treatment in unfit individuals is moderate and feasible for many middle-aged and older adults through moderate intensity physical activity such as …
Read more on Forbes

 

Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals

Filed under: drug treatment news 2011

28, 2012 — /PRNewswire/ — Sound Pharmaceuticals, Inc. is honored to have Bruce A. Beutler, a recipient of the 2011 Nobel Prize in Physiology or Medicine for his discoveries involving the activation of innate immunity, join the company as a scientific …
Read more on Sacramento Bee